Literature DB >> 30720503

Proving the Effectiveness of the Fundamentals of Robotic Surgery (FRS) Skills Curriculum: A Single-blinded, Multispecialty, Multi-institutional Randomized Control Trial.

Richard M Satava1, Dimitrios Stefanidis2, Jeffrey S Levy3, Roger Smith4, John R Martin2, Sara Monfared2, Lava R Timsina2, Ara Wardkes Darzi5, Andrea Moglia6, Timothy C Brand7, Ryan P Dorin8, Kristoffel R Dumon9, Todd D Francone10, Evangelos Georgiou11, Alvin C Goh12, Jorge E Marcet13, Martin A Martino14, Ranjan Sudan15, Justin Vale6, Anthony G Gallagher16,17.   

Abstract

MINI: Question: Is the Fundamentals of Robotic Surgery (FRS) proficiency-based progression curriculum effective for teaching basic robotic surgery skills?
FINDINGS: In an international multi-institutional, multispecialty, blinded, randomized control trial, implementation of the FRS skills curriculum using various simulation platforms led to improved performance of surgical trainees on a transfer test compared with controls.Meaning: The FRS is an effective simulation-based course for training to proficiency on basic robotic surgery skills before surgeons apply those skills clinically.
OBJECTIVE: To demonstrate the noninferiority of the fundamentals of robotic surgery (FRS) skills curriculum over current training paradigms and identify an ideal training platform. SUMMARY BACKGROUND DATA: There is currently no validated, uniformly accepted curriculum for training in robotic surgery skills.
METHODS: Single-blinded parallel-group randomized trial at 12 international American College of Surgeons (ACS) Accredited Education Institutes (AEI). Thirty-three robotic surgery experts and 123 inexperienced surgical trainees were enrolled between April 2015 and November 2016. Benchmarks (proficiency levels) on the 7 FRS Dome tasks were established based on expert performance. Participants were then randomly assigned to 4 training groups: Dome (n = 29), dV-Trainer (n = 30), and DVSS (n = 32) that trained to benchmarks and control (n = 32) that trained using locally available robotic skills curricula. The primary outcome was participant performance after training based on task errors and duration on 5 basic robotic tasks (knot tying, continuous suturing, cutting, dissection, and vessel coagulation) using an avian tissue model (transfer-test). Secondary outcomes included cognitive test scores, GEARS ratings, and robot familiarity checklist scores.
RESULTS: All groups demonstrated significant performance improvement after skills training (P < 0.01). Participating residents and fellows performed tasks faster (DOME and DVSS groups) and with fewer errors than controls (DOME group; P < 0.01). Inter-rater reliability was high for the checklist scores (0.82-0.97) but moderate for GEARS ratings (0.40-0.67).
CONCLUSIONS: We provide evidence of effectiveness for the FRS curriculum by demonstrating better performance of those trained following FRS compared with controls on a transfer test. We therefore argue for its implementation across training programs before surgeons apply these skills clinically.

Year:  2019        PMID: 30720503     DOI: 10.1097/SLA.0000000000003220

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  2 in total

Review 1.  The safety of urologic robotic surgery depends on the skills of the surgeon.

Authors:  Erika Palagonia; Elio Mazzone; Geert De Naeyer; Frederiek D'Hondt; Justin Collins; Pawel Wisz; Fijs W B Van Leeuwen; Henk Van Der Poel; Peter Schatteman; Alexandre Mottrie; Paolo Dell'Oglio
Journal:  World J Urol       Date:  2019-08-19       Impact factor: 4.226

Review 2.  Artificial intelligence and robotics: a combination that is changing the operating room.

Authors:  Iulia Andras; Elio Mazzone; Fijs W B van Leeuwen; Geert De Naeyer; Matthias N van Oosterom; Sergi Beato; Tessa Buckle; Shane O'Sullivan; Pim J van Leeuwen; Alexander Beulens; Nicolae Crisan; Frederiek D'Hondt; Peter Schatteman; Henk van Der Poel; Paolo Dell'Oglio; Alexandre Mottrie
Journal:  World J Urol       Date:  2019-11-27       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.